<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-332
Date of Submission: 2025-07-15

This report was submitted by a Other Healthcare Professional from Johnson, Price and Perez Medical Center concerning patient ANON-PX-4595. The subject is a 35-year-old male with a significant medical history including hypertension, type 2 diabetes, asthma. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Gabapentin administered via the Topical route at a dosage of 58mg, initiated on 2025-07-04 for Neuropathic pain and discontinued on 2025-07-13.

On approximately 2025-07-12, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Stevens-Johnson syndrome, Dizziness. The Stevens-Johnson syndrome was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed want and advised push. The current patient status regarding this symptom is 'Recovered'. The Dizziness was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 8 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

</data>
report_id: ADR-2025-332
report_date: '2025-07-15'
patient_details:
  patient_id: ANON-PX-4595
  gender: Male
  relevant_history:
  - hypertension
  - type 2 diabetes
  - asthma
  age_at_reaction: 35
suspected_drugs:
- drug_name: Gabapentin
  dosage: 58mg
  route_of_administration: Topical
  start_date: '2025-07-04'
  indication_for_use: Neuropathic pain
  end_date: '2025-07-13'
adverse_reactions:
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2025-07-12'
  severity: Mild
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed want and advised push.
- symptom_name: Dizziness
  onset_date: '2025-07-12'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
  naranjo_score: 8
reporting_facility: Johnson, Price and Perez Medical Center
reporter_type: Other Healthcare Professional
